MRP ₹131
(Inclusive of all Taxes)
₹19.6 Cashback (15%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Manufacturer/Marketer :
Sun Pharmaceutical Industries Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Aliskiren with Metosartan CH 50 mg/6.25 mg/40 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Metosartan CH 50 mg/6.25 mg/40 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking tizanidine with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Taking tizanidine with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking perindopril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking ramipril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking ramipril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of amiloride with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Coadministration of enalapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Potassium acetate can make Metosartan CH 50 mg/6.25 mg/40 mg Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Metosartan CH 50 mg/6.25 mg/40 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Metosartan CH 50 mg/6.25 mg/40 mg Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Metosartan CH 50 mg/6.25 mg/40 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Alcohol
Unsafe
Avoid or limit consumption of alcohol while taking Metosartan CH 50/6.25/40mg Tablet as it might cause increased dizziness.
Pregnancy
Caution
Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks. Metosartan CH 50/6.25/40mg Tablet should be discontinued during the second and third trimester of pregnancy as it might affect the developing foetus.
Breast Feeding
Consult your doctor
Please consult your doctor; your doctor will decide whether Metosartan CH 50/6.25/40mg Tablet can be taken by breastfeeding mothers or not.
Driving
Unsafe
Metosartan CH 50/6.25/40mg Tablet may cause dizziness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
A dose adjustment may be needed. Please consult your doctor if you have liver problems or any concerns about this.
Kidney
Caution
A dose adjustment may be needed. Please consult your doctor if you have kidney problems or any concerns about this.
Children
Unsafe
Metosartan CH 50/6.25/40mg Tablet is not recommended for children as safety and effectiveness have not been established.
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
